1-tert-butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)ureea,
PD 173074,
PD-173074,
PD173074,
219580-11-7,
PD173074,
PD 173074,
PD-173074,
1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea,
DXCUKNQANPLTEJ-UHFFFAOYSA-N,
1-tert-butyl-3-[2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea,
UNII-A4TLL8634Y,
A4TLL8634Y,
CHEMBL189584,
PD-0173074,
CHEBI:63448,
MFCD08705327,
1-tert-butyl-3-(2-(4-(diethylamino)butylamino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea,
FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074,
AK105355,
1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea,
3-tert-butyl-1-(2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea,
C28H41N7O3,
2fgi,
1-t-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)-pyrido[2,3-d]pyrimidin-7-yl)urea,
1-tert-butyl-3-[2-[4-(diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea,
SMR000568412,
PubChem22593,
AC1L1BE8,
JSPY-st000263,
MLS001074892,
MLS006011101,
SCHEMBL177946,
Pyrido[2,3-d]pyrimidine 12,
AC1Q5L34,
BDBM6190,
GTPL5037,
CTK4E8045,
AOB2517,
DTXSID30176363,
EX-A197,
SYN1176,
BCPP000121,
HMS2233G17,
HMS3265E09,
HMS3265E10,
HMS3265F09,
HMS3265F10,
HMS3371E08,
HMS3648A10,
HMS3654L09,
BCP02368,
KS-00000PL5,
ZINC3870533,
ABP000888,
AN-324,
ANW-73236,
s1264,
AKOS016008595,
BCP9001065,
CS-0182,
KIN0000180,
QC-7737,
RL02670,
SB19382,
NCGC00165863-01,
NCGC00165863-02,
4CA-0978,
AC-24850,
AJ-46337,
AS-16310,
BC659951,
HY-10321,
SC-90094,
AB0033759,
AX8224166,
RT-012706,
ST2403291,
FT-0673540,
P2474,
SW218104-2,
X7486,
PD 173074, >=96% (HPLC), powder,
A25450,
W-5382,
PD173074/PD-173074/,
SR-01000837541,
J-014372,
J-523314,
SR-01000837541-2,
PD173074, 219580-11-7,
1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-y,
1-(tert-Butyl)-3-[7-[[4-(diethylamino)butyl]amino]-3-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-2-yl]urea,
1-tert-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)urea,
N-(tert-Butyl)-N -[2-[[4-(diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea,
N-[2-[[4-(Dethylamno)butyl]amno]-6-(3,5-dmethoxyphenyl)pyrdo[2,3-d ]pyrmdn-7-yl]-n'-(1,1-dmethylethyl)urea,
N-[2-[[4-(Diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea,
N-[2-[[4-(Diethylamino)butyl]amino] -6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-y l]-N'-(1,1-dimethylethyl)urea,
N-[2-[[4-(Diethylamino)butyl]amino]-6-(3,5- dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1- dimethylethyl)urea,
N-[2-[[4-(diethylaMino)butyl]aMino]-6-(3,5-diMethoxyphenyl)pyrido[2,3-d ]pyriMidin-7-yl]-N'-(1,1-diMethylethyl)UREA,
N-[2-[[4-(diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea,
N-[2-[[4-(Diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea,
PD 173074;n-[2-[[4-(diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-n'-(1,1-dimethylethyl)urea,
FGFR inhibitors,
D0VF6E,
cc-523,
CID1401,
AR-1C5653,
PX-478,
A8253,
A10703,
C115711,
PD1,
1-tert-butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)ureea,
114560-48-4,
22454-96-2,
685898-44-6,